Processa Pharmaceuticals Aktie 132289633 / US74275C3043
0.61
USD
-0.01
USD
-0.82%
06.02.2025
BTT
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Processa Pharmaceuticals Dividenden Kalender
Datum | Name | Rendite * | Dividende | Währung |
---|---|---|---|---|
2023 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2022 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2021 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2020 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2019 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2018 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2017 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2016 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2015 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
2014 | Processa Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Processa Pharmaceuticals Inc Registered Shs Termine
Unternehmen | Event | Datum |
---|---|---|
Processa Pharmaceuticals Inc Registered Shs | Quartalszahlen | 27.03.2025 |
Processa Pharmaceuticals Inc Registered Shs | Quartalszahlen | 07.08.2025 |
Processa Pharmaceuticals Inc Registered Shs | Quartalszahlen | 05.11.2025 |
Processa Pharmaceuticals Inc Registered Shs | Quartalszahlen | 06.08.2026 |
Processa Pharmaceuticals Inc Registered Shs vergangene Termine
Terminart | Info | Datum |
---|---|---|
Quartalszahlen | Q3 2024 Earnings Release | 30.10.2024 |
Quartalszahlen | Q2 2024 Earnings Release | 28.08.2024 |
Hauptversammlung | Annual General Meeting | 28.06.2024 |
Hauptversammlung | Annual General Meeting | 27.06.2023 |
Quartalszahlen | Q4 2022 Earnings Release | 30.03.2023 |
Quartalszahlen | Q3 2022 Earnings Release | 08.11.2022 |
Quartalszahlen | Q2 2022 Earnings Release | 11.08.2022 |
Hauptversammlung | Annual General Meeting | 11.07.2022 |
Quartalszahlen | Q1 2022 Earnings Release | 12.05.2022 |
Quartalszahlen | Q4 2021 Earnings Release | 30.03.2022 |
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 83.57 |
Walleye Capital LLC | 11.34 |
Citadel Securities GP LLC | 8.53 |
Spinnaker Trust | 2.08 |
Coastal Bridge Advisors LLC | 1.76 |
Yuhan Corp. | 1.69 |
Renaissance Technologies LLC | 1.57 |
Raymond James Financial Services, Inc. | 1.32 |
Sabby Management LLC | 1.31 |
Janney Montgomery Scott LLC | 1.25 |
RBC Capital Markets LLC | 1.25 |
Vanguard Total Stock Market ETF | 1.20 |
State Street Corp. | 1.16 |
Northern Trust Investments, Inc.(Investment Management) | 0.76 |
G1 Execution Services LLC | 0.76 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 13 | 15 | 13 | 14 | 15 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 | 2 | 1 | 16 | 18 |
Summe Anlagevermögen | 0 | 13 | 11 | 11 | 10 |
Summe Aktiva | 3 | 15 | 12 | 27 | 29 |
Bilanz (in Mio. USD) - Passiva
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Fremdkapital | 3 | 4 | 4 | 4 | 3 |
Summe Eigenkapital | 0 | 12 | 8 | 23 | 25 |
Summe Passiva | 3 | 15 | 12 | 27 | 29 |